SGLT2 inhibitors – their expanding role in diabetes care
Speakers: Per-Henrik Groop and Prof Juliana Chan
Time: breakfast served from 6.30am | session 7.00am to 8.00am
This is a non-promotional Scientific Exchange Meeting, which all registered delegates are invited to attend. There is increased interest in SGLT2 inhibitors as glucose lowering agents as a result of recent clinical trials that have identified additional effects of this class of drugs including weight loss and blood pressure lowering. Interest has been further heightened by recent data that goes beyond these effects.
This meeting will review not only the current role of SGLT2 inhibitors in the management of type 2 diabetes but also their place in the overall treatment plan as addressed in recently modified national and international guidelines. In addition, ongoing data on the longer term effects of these agents on other sites of diabetes related end organ injury including the kidney and their role as glucose lowering agents in combination with other drugs including insulin will be addressed.
Visit the ADS ADEA Conference website for more detail- http://ads-adea.org.au/industry-trade-breakfast-symposia/
*NB: The entrance to Central Room B is via the Exhibition Hall